Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Phase 1 Terminated 7 enrolled Queen's University Allergan · collab

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of intraprostatic injection of Botox for the treatment of men diagnosed with chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Timeline

Start: 2006-01
Primary completion: 2009-09
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Botulinum toxin type A	Protein / enzyme biologic	300 iu	Other

Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Summary

Timeline

Drugs

Indications